Quite a few studies have revealed the clinical values regarding the outcome predictions in the cohort of the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) trial and decision-making with the SYNTAX score. The Evaluation of Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left-Main Revascularization (EXCEL) and Nordic-Baltic-British left main revascularization (NOBLE) studies are the largest international randomized studies so far, comparing percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in the treatment of left main coronary artery disease. Unfortunately, both studies failed to validate the value of the SYNTAX score in the...
AimsThe SYNTAX (SX) score, an interesting tool to characterize the severity of the coronary artery d...
’To analyze the impact of additional coronary artery disease, quantified by the SYNTAX (SYNergy betw...
OBJECTIVES: The SYNTAX score II (SSII) was developed from the SYNTAX trial to predict the 4-year all...
ObjectivesThe purpose of our study was to investigate the utility of the SYNTAX (Synergy Between Per...
ObjectivesThis study aimed to validate the SYNTAX (Synergy between PCI with Taxus and Cardiac Surger...
ObjectiveThe SYNergy between percutaneous intervention with TAXus drug eluting stents and cardiac su...
Background. The SYNTAX score, a comprehensive angiographic scoring system, was recently developed as...
Objectives: To reassess the reproducibility of the SYNTAX score. Background: The SYNTAX score appear...
AbstractIn recent years an angiographic score was introduced in clinical practice to stratified diff...
Background The SYNTAX score (SS) is a determinant of outcome in patients undergoing percutaneous cor...
textabstractObjectives: To assess the clinical profile and long-term mortality in SYNTAX score II ba...
AbstractDespite the fact that CABG is the standard of care for patients with multivessel coronary ar...
The introduction of the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) score has prompt...
Background: SYNTAX score II (SSII) provides individualized estimates of 4-year mortality after coron...
OBJECTIVES: We aimed to investigate the prognostic utility of the anatomical CABG SYNTAX and logisti...
AimsThe SYNTAX (SX) score, an interesting tool to characterize the severity of the coronary artery d...
’To analyze the impact of additional coronary artery disease, quantified by the SYNTAX (SYNergy betw...
OBJECTIVES: The SYNTAX score II (SSII) was developed from the SYNTAX trial to predict the 4-year all...
ObjectivesThe purpose of our study was to investigate the utility of the SYNTAX (Synergy Between Per...
ObjectivesThis study aimed to validate the SYNTAX (Synergy between PCI with Taxus and Cardiac Surger...
ObjectiveThe SYNergy between percutaneous intervention with TAXus drug eluting stents and cardiac su...
Background. The SYNTAX score, a comprehensive angiographic scoring system, was recently developed as...
Objectives: To reassess the reproducibility of the SYNTAX score. Background: The SYNTAX score appear...
AbstractIn recent years an angiographic score was introduced in clinical practice to stratified diff...
Background The SYNTAX score (SS) is a determinant of outcome in patients undergoing percutaneous cor...
textabstractObjectives: To assess the clinical profile and long-term mortality in SYNTAX score II ba...
AbstractDespite the fact that CABG is the standard of care for patients with multivessel coronary ar...
The introduction of the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) score has prompt...
Background: SYNTAX score II (SSII) provides individualized estimates of 4-year mortality after coron...
OBJECTIVES: We aimed to investigate the prognostic utility of the anatomical CABG SYNTAX and logisti...
AimsThe SYNTAX (SX) score, an interesting tool to characterize the severity of the coronary artery d...
’To analyze the impact of additional coronary artery disease, quantified by the SYNTAX (SYNergy betw...
OBJECTIVES: The SYNTAX score II (SSII) was developed from the SYNTAX trial to predict the 4-year all...